M Elizabeth Sublette1,2, Stephanie Cheung1,3, Evan Lieberman2, Shoahua Hu4, J John Mann1,2,5, Anne-Catrin Uhlemann6, Jeffrey M Miller1,2. 1. Department of Psychiatry, Columbia University, NY, USA. 2. Department of Molecular Imaging & Neuropathology, New York State Psychiatric Institute, NY, USA. 3. Division of Consultation-Liaison Psychiatry, Columbia University, New York, NY, USA. 4. Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 5. Department of Radiology, Columbia University, NY, NY, USA. 6. Microbiome & Pathogen Genomics Core, Department of Medicine, Division of Infectious Diseases, Columbia University, New York, NY, USA.
Abstract
OBJECTIVES: The microbiome is a rapidly advancing biomedical frontier with relevance for psychiatric illness. The gut microbiota interact with the central nervous system bidirectionally through the gut-brain axis and generate substances that may influence host metabolism, including short-chain fatty acids such as butyrate. Understanding gut microbiota in bipolar disorder (BD) may suggest new disease markers and treatment approaches. METHODS: A PubMed search was performed on January 7, 2020 using terms "bipolar AND (microbiome OR microbiota)", for articles in English in which the study population included a distinct BD group and the gut microbiota/microbiome was assessed. RESULTS: Thirteen articles met the inclusion criteria. In four out of five studies that reported on group comparisons with respect to diversity, lower α-diversity was observed in BD relative to healthy controls (HC). The most convergent taxonomic finding was that in four studies, one particular clade distinguished gut microbiota between BD and HC: family Ruminococcaceae, genus Faecalibacterium, and species Faecalibacterium prausnitzii. Members of this clade, known for butyrate production, were reduced in BD relative to HC in three studies but elevated in a fourth. Additionally, genera Bacteroides or Bacteroides-Prevotella group species were elevated in BD in two studies but lower in a third. CONCLUSIONS: Despite few studies and modest sample sizes, salient findings suggest that low α-diversity and dysbiosis with respect to abundance of Faecalibacterium and Bacteroides may characterize BD in both a trait and state-dependent fashion. Decreased richness and butyrate production also foster inflammation, which may be a hitherto unrecognized part of the pathophysiology underlying BD. This article is protected by copyright. All rights reserved.
OBJECTIVES: The microbiome is a rapidly advancing biomedical frontier with relevance for psychiatric illness. The gut microbiota interact with the central nervous system bidirectionally through the gut-brain axis and generate substances that may influence host metabolism, including short-chain fatty acids such as butyrate. Understanding gut microbiota in bipolar disorder (BD) may suggest new disease markers and treatment approaches. METHODS: A PubMed search was performed on January 7, 2020 using terms "bipolar AND (microbiome OR microbiota)", for articles in English in which the study population included a distinct BD group and the gut microbiota/microbiome was assessed. RESULTS: Thirteen articles met the inclusion criteria. In four out of five studies that reported on group comparisons with respect to diversity, lower α-diversity was observed in BD relative to healthy controls (HC). The most convergent taxonomic finding was that in four studies, one particular clade distinguished gut microbiota between BD and HC: family Ruminococcaceae, genus Faecalibacterium, and species Faecalibacterium prausnitzii. Members of this clade, known for butyrate production, were reduced in BD relative to HC in three studies but elevated in a fourth. Additionally, genera Bacteroides or Bacteroides-Prevotella group species were elevated in BD in two studies but lower in a third. CONCLUSIONS: Despite few studies and modest sample sizes, salient findings suggest that low α-diversity and dysbiosis with respect to abundance of Faecalibacterium and Bacteroides may characterize BD in both a trait and state-dependent fashion. Decreased richness and butyrate production also foster inflammation, which may be a hitherto unrecognized part of the pathophysiology underlying BD. This article is protected by copyright. All rights reserved.
Authors: Bedayah Amro; Maria Eugenia Ramirez Aristondo; Shaima Alsuwaidi; Basma Almaamari; Zeinab Hakim; Muna Tahlak; Arnaud Wattiez; Philippe R Koninckx Journal: Int J Environ Res Public Health Date: 2022-05-31 Impact factor: 4.614
Authors: Jacek Karczewski; Aleksandra Zielińska; Rafał Staszewski; Piotr Eder; Agnieszka Dobrowolska; Eliana B Souto Journal: Int J Mol Sci Date: 2022-05-30 Impact factor: 6.208
Authors: Ning O Zhao; Natasha Topolski; Massimo Tusconi; Erika M Salarda; Christopher W Busby; Camila N N C Lima; Anilkumar Pillai; Joao Quevedo; Tatiana Barichello; Gabriel R Fries Journal: Brain Behav Immun Health Date: 2022-03-05
Authors: A J McGuinness; J A Davis; S L Dawson; A Loughman; F Collier; M O'Hely; C A Simpson; J Green; W Marx; C Hair; G Guest; M Mohebbi; M Berk; D Stupart; D Watters; F N Jacka Journal: Mol Psychiatry Date: 2022-02-22 Impact factor: 13.437